Clonal diversity, antimicrobial resistance, and genome features among non-fermenting Gram-negative bacteria isolated from patients with cystic fibrosis in Russia

Global Increase of Antibiotic Resistance Genes in Conjugative Plasmids

(2023) Xiaolong Wang et al.   Microbiology Spectrum

Distribution and Characteristics of Bacteria Isolated from Cystic Fibrosis Patients with Pulmonary Exacerbation

(2022) Soroor Erfanimanesh et al.   Canadian Journal of Infectious Diseases & Medical Microbiology

Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis

(2022) Eitan Kerem et al.   Journal of Cystic Fibrosis

Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection

(2021) Roberto Rosales-Reyes et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients

(2020) C.A. Colque et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease

(2020) Siddhartha G. Kapnadak et al.   Journal of Cystic Fibrosis

Achromobacter Infections and Treatment Options

(2020) Burcu Isler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literature

(2020) M. Carugati et al.   BMC INFECTIOUS DISEASES

Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update

(2020) Ester del Barrio-Tofiño et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients

(2019) Roxana Zamudio et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Susceptibility of Pseudomonas aeruginosa recovered from cystic fibrosis patients to murepavadin and thirteen comparator antibiotics

(2019) Miquel B. Ekkelenkamp et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

On Burkholderiales order microorganisms and cystic fibrosis in Russia

(2018) Olga L. Voronina et al.   BMC GENOMICS

Horizontal transfer of antibiotic resistance genes in clinical environments

(2018) Nicole A. Lerminiaux et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis

(2018) Michael D. Parkins et al.   CLINICAL MICROBIOLOGY REVIEWS

Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract

(2018) Megan R. Kiedrowski et al.   Frontiers in Immunology

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches

(2017) Viola C. Scoffone et al.   Frontiers in Microbiology

The Complex Relationship between Virulence and Antibiotic Resistance

(2017) Meredith Schroeder et al.   Genes

Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe

(2016) Muhammad-Hariri Mustafa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Type IV secretion systems and genomic islands-mediated horizontal gene transfer in Pseudomonas and Haemophilus

(2015) Mario Juhas   MICROBIOLOGICAL RESEARCH

Factors Influencing Acquisition of Burkholderia cepacia Complex Organisms in Patients with Cystic Fibrosis

(2013) K. A. Ramsay et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Improvements on colony morphology identification towards bacterial profiling

(2013) Ana Margarida Sousa et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates

(2011) G.A. Tramper-Stranders et al.   CLINICAL MICROBIOLOGY AND INFECTION

Insertion sequence evolutionary patterns highlight convergent genetic inactivations and recent genomic island acquisitions among epidemic Burkholderia cenocepacia

(2011) A. Graindorge et al.   JOURNAL OF MEDICAL MICROBIOLOGY